School of Nursing

undefined

WAN Guangming

Chief nurse practitioner

Email:308683296@qq.com

Tel:18017321632

Research areas:Infusion nursing, Clinical nursing of chest tumor,   Nurse management

Bio

  • Master's degree, chief nurse practitioner, supervisor of specialized master's degree in the School of Nursing of Shanghai Jiao Tong University.

  • I am currently the Chief Nurse of the Department of Outpatient and Emergency Medicine; Head of the Intravenous Nursing Team; Member of the Nursing Quality Management Committee; Head of the Emergency and Unexpected Events Team; Head of the Quality Nursing Service Team at the Chest Hospital of Shanghai Jiao Tong University.

  • I professionally serve as a committee member of Shanghai Nursing Society Intravenous Infusion Committee; lecturer of PICC training course of Shanghai Nursing Society; member of Shanghai Science and Technology Expert Pool; member of the 27th Chinese Nursing Society Sedation Expert Pool; senior member of Chinese Nursing Society; standing committee member of Nursing Branch of Pulmonary Tumor Specialty Committee of Chinese Society of Medical Education; editorial board member of Chinese Journal of Modern Nursing; Shanghai Society of Integrative Medicine Vice Chairman of the Fourth Professional Committee of Emergency Medicine of Shanghai

  • In the past five years, I have published more than 30 nursing papers in Chinese core journals and three SCI papers as the first author and corresponding author. I have undertaken and completed eight projects of Shanghai Chest Hospital Science and Technology Development Fund, one project of Shanghai Health Planning Commission, four projects of Shanghai Jiao Tong University Medical College Science and Technology Fund, one project of Shanghai Nursing Quality Control Center and one project of China Hospital Development Institute as the first person in charge.

Selected Publications

  • Wang Zheng, Wan Guangming. Multifactor analysis of medical mucus-related skin injury at the site of central venous catheter placement via peripheral veins in patients with lung cancer. Chinese Journal of Clinical Nutrition, 2018,26(3):191-194.

  • Chen Hao Yun, Wan Guangming. Survey on the current situation of intravenous infusion in specialized hospitals. Journal of PLA Hospital Management, 2018,25(7):692-695.

  • Zhao Jian, Wan Guangming. The introduction of foreign nurses' career continuity development model and its inspiration to China. Journal of Liberation Army Nursing, 2018, 35(23):51-53.

  • Tang W Y, Wan G G. Analysis of the effect of exploring the guide wire in-out method on the success rate of ectopic repositioning during PICC placement. China Medical Equipment,2019,16(3):28-30.

  • Wan Guangming, Wang Yi, Pan Luyi, Chen Pei, Zhong Hua. Observation on the effect of calcium alginate wound dressing yufang lung cancer patients with PICC puncture site complications, China Medical Herald,2019,16(31):169-172.

  • Wang Yi, Wan Guangming, Chen Pei. Construction and application of nurse-patient communication platform in patients with PICC with tube. Modern Scientific Instruments, 2020(1):104-106.

  • Wang Yi, Wan Guangming. Construction and application of an internet platform for medium and long-term intravenous infusion access. Journal of Interventional Radiology, 2021, 30(7):730-733.

  • Wang Yi, Wan Guangming, Chen Pei. Construction of a postoperative surgical wound management process in a sensory control situation, Journal of Naval Military Medicine,2021, 42(4):506-508.

  • Pei Chen, Bingqian Zhu, Guangming Wan, LiyuanQin. The incidence of asymptomatic thrombosis related to peripherally inserted central catheter in adults: A systematic review and meta-analysis People’s. Nursing open.2021,8(5):2249-2261.SCI影响因子:1.762

  • Pei Chen, Guangming Wan, Bingqian Zhu. Incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer,Journal of Advanced Nursing   2020,10(11):14657-14666.sci影响因子:3.187

  • Yan Wang, Jian Zhao, Guangming Wan . Prolong the flushing and locking interval of TIVAD is feasible in COVID-19: An overview of systematic reviews. J Vasc Access. 2022 Apr 16:11297298221086129. doi: 10.1177/11297298221086129. Epub ahead of print. PMID: 35430915.